Your session is about to expire
← Back to Search
Cervical Retraction Device for Post-Procedural Pain
Study Summary
This trial will test a suction-based method of engaging the cervix, which may diminish pain and discomfort.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have gone through menopause.I can give my consent in English or Spanish.I am going for an IUD insertion or endometrial biopsy.I have an abnormal growth or area in my cervix.I have used narcotics or Benzodiazepines before the procedure.
- Group 1: Standard Cervical Tenaculum
- Group 2: Bioceptive Cervical Retraction Device
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What criteria need to be fulfilled for individuals to participate in this research?
"Acceptance into this clinical trial necessitates that potential participants suffer from pain due to a particular procedure and are between 18-45 years old. Presently, the team is looking for 24 volunteers."
Does the enrollment criteria for this medical trial encompass individuals younger than sixty years of age?
"The age range for eligibility is 18-45, as specified in the criteria for participant selection."
Are there any eligibility requirements to join this research project?
"The clinicaltrials.gov page confirms that this trial is no longer recruiting patients, with the original listing being posted on September 1st 2014 and last updated July 18th 2017. However, there are currently other trials actively enrolling participants at the moment."
Share this study with friends
Copy Link
Messenger